StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD – Free Report) in a research report sent to investors on Thursday morning. The firm issued a sell rating on the medical equipment provider’s stock.
Aethlon Medical Price Performance
Shares of AEMD stock opened at $0.38 on Thursday. The stock has a market cap of $5.36 million, a PE ratio of -0.10 and a beta of 1.74. The stock has a 50-day moving average of $0.40 and a 200-day moving average of $0.55. Aethlon Medical has a one year low of $0.24 and a one year high of $2.35.
Aethlon Medical (NASDAQ:AEMD – Get Free Report) last posted its earnings results on Wednesday, August 14th. The medical equipment provider reported ($0.34) earnings per share for the quarter, topping the consensus estimate of ($0.44) by $0.10. During the same quarter last year, the business earned ($1.30) earnings per share. As a group, research analysts anticipate that Aethlon Medical will post -1.1 earnings per share for the current year.
About Aethlon Medical
Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.
See Also
- Five stocks we like better than Aethlon Medical
- When to Sell a Stock for Profit or Loss
- Battle of the Retailers: Who Comes Out on Top?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- The Basics of Support and Resistance
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
